je.st
news
Drug Conjugates Lure Investment
2013-10-21 10:15:43| Biotech - Topix.net
Only two antibody-drug conjugates are on the market- Roche's Kadcyla for breast cancer and Seattle Genetics 's Adcetris for lymphoma-but developers are stepping up investment in this new drug class.
Tags: investment
drug
lure
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||